GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » Cyclically Adjusted Revenue per Share

Level Bio AB (XSAT:LEVBIO) Cyclically Adjusted Revenue per Share : kr0.57 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Level Bio AB's adjusted revenue per share for the three months ended in Mar. 2024 was kr0.087. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr0.57 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Level Bio AB's average Cyclically Adjusted Revenue Growth Rate was 1.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Level Bio AB was 15.20% per year. The lowest was 12.50% per year. And the median was 13.85% per year.

As of today (2024-06-06), Level Bio AB's current stock price is kr0.288. Level Bio AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr0.57. Level Bio AB's Cyclically Adjusted PS Ratio of today is 0.51.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Level Bio AB was 7.67. The lowest was 0.40. And the median was 1.84.


Level Bio AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Level Bio AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB Cyclically Adjusted Revenue per Share Chart

Level Bio AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.40 0.47 0.55 0.57

Level Bio AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.57 0.57 0.57 0.57

Competitive Comparison of Level Bio AB's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Level Bio AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Bio AB's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Level Bio AB's Cyclically Adjusted PS Ratio falls into.



Level Bio AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Level Bio AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.087/132.2054*132.2054
=0.087

Current CPI (Mar. 2024) = 132.2054.

Level Bio AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.096 99.788 0.127
201406 0.099 100.432 0.130
201412 0.000 100.225 0.000
201503 0.102 99.950 0.135
201506 0.101 99.995 0.134
201509 0.089 100.228 0.117
201512 0.161 100.276 0.212
201603 0.099 100.751 0.130
201606 0.104 101.019 0.136
201609 0.136 101.138 0.178
201612 0.172 102.022 0.223
201703 0.135 102.022 0.175
201706 0.000 102.752 0.000
201709 0.000 103.279 0.000
201712 0.000 103.793 0.000
201803 0.071 103.962 0.090
201806 0.000 104.875 0.000
201809 0.088 105.679 0.110
201812 0.105 105.912 0.131
201903 0.068 105.886 0.085
201906 0.098 106.742 0.121
201909 0.066 107.214 0.081
201912 0.089 107.766 0.109
202003 0.120 106.563 0.149
202006 0.117 107.498 0.144
202009 0.093 107.635 0.114
202012 0.115 108.296 0.140
202103 0.184 108.360 0.224
202106 0.251 108.928 0.305
202109 0.110 110.338 0.132
202112 0.180 112.486 0.212
202203 0.209 114.825 0.241
202206 0.095 118.384 0.106
202209 0.092 122.296 0.099
202212 0.153 126.365 0.160
202303 0.133 127.042 0.138
202306 0.088 129.407 0.090
202309 0.112 130.224 0.114
202312 0.077 131.912 0.077
202403 0.087 132.205 0.087

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Level Bio AB  (XSAT:LEVBIO) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Level Bio AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.288/0.57
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Level Bio AB was 7.67. The lowest was 0.40. And the median was 1.84.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Level Bio AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Level Bio AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Bio AB (XSAT:LEVBIO) Business Description

Traded in Other Exchanges
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines